This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
EV-302
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
mCRPC with Bone Metastasis
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Actionable Clinical Data
Kidney Cancer
ZIRCON
Trials in Progress
Trials in Progress
Bladder Cancer
BOND-003 Cohort P
CORE-008
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
ASCO GU 2025
SUO 2024
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Conference Highlights
AUA 2017
AUA 2017
Prostate Cancer
Bladder Cancer
Kidney Cancer
Testis & Penile Cancers
BPH
GU Reconstruction
Infections & Inflammation
Sexual Function
Stone Disease - Endourology & Technology
Urinary Incontinence
Press Releases
AUA 2017 Prostate Cancer
Viewing 21-40 of 132 articles
AUA 2017: Diabetes Mellitus, Metformin and Prostate Cancer – Results of a Prostate Cancer Database Analysis
AUA 2017: The impact of anxiety and depression on functional outcome in patients who underwent radical prostatectomy
AUA 2017: Predicting Competing Mortality in Patients Undergoing Radical Prostatectomy at an Age of 70 years or older
AUA 2017: PSMA PET/CT Improves Biochemical Response after Salvage Lymph Node Dissection for Nodal Recurrence in Prostate Cancer Patients
AUA 2017: John K. Lattimer Lecture – Net benefit and clinical decision-making in urology
AUA 2017: Prostatic Tissue Androgen Levels as Prognostic Factor for Men with Metastatic Castration-resistant Prostate Cancer
AUA 2017: Older Age at Diagnosis and Disease Volume Predict Upgrading on Confirmatory Biopsy in Prostate Cancer Patients Being Considered for Active Surveillance
AUA 2017: Active Surveillance is a Viable Option for Men with Borderline Low-Risk Prostate Cancer
AUA 2017: Active Surveillance for Low-Risk Prostate Cancer in Men Under 60 Years of Age
AUA 2017: Erectile-function and Oncologic Outcomes After Open Retropubic and Robot-assisted Radical Prostatectomy: Results From a Large, Prospective Swedish Trial
AUA 2017: Analysis of the predictive utility of Prognostic Grade Groups (PGG) for predicting perioperative oncologic outcomes of radical prostatectomy in the Shared Equal Access Regional Cancer Hospital (SEARCH) database
AUA 2017: Detection of Circulating Tumor Cell in the Patients with Prostate Cancer Using Novel Viral Marker OBP-1101
AUA 2017: Interim Results of a Novel ‘Adaptive’ Registration-Utility Trial Assessing the Performance of Exodx (Prostate) Intelliscore (EPI): A Non-DRE Urine Exosome Gene Expression Assay to Predict High Grade Disease on Initial Biopsy
AUA 2017: Tumor Board: Prostate Cancer
AUA 2017: Laparoscopic Radical Prostatectomy
AUA 2017: Robotic Perineal Prostatectomy (Kaouk)
AUA 2017: Radical Perineal Prostatectomy
AUA 2017: The Evolution of Radical Prostatectomy
AUA 2017: Best Abstract – Focal therapy of prostate cancer: Defining appropriate treatment margins using MRI: whole mount co-registration
AUA 2017: Best Abstract - Novel in vitro Organoid Technology to Facilitate a Precision Medicine Approach in the Management of Men with Biochemical Recurrence of Prostate Cancer
1
2
3
4
5
6
7
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free